COVID-19 Vaccines in Young Children—Reassuring Evidence for Parents
Author:
Affiliation:
1. Vaccine Education Center, Children’s Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia
Publisher
American Medical Association (AMA)
Subject
Pediatrics, Perinatology and Child Health
Link
https://jamanetwork.com/journals/jamapediatrics/articlepdf/2800744/jamapediatrics_offit_2023_ed_220040_1680182460.79732.pdf
Reference15 articles.
1. Assessment of efficacy and safety of mRNA COVID-19 vaccines in children aged 5 to 11 years: a systematic review and meta-analysis.;Watanabe;JAMA Pediatr
2. Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 years of age.;Walter;N Engl J Med,2022
3. Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19-associated emergency department and urgent care encounters and hospitalizations among nonimmunocompromised adolescents aged 5-17 years—VISION Network, 10 states, April 2021-January 2022.;Klein;MMWR Morb Mortal Wkly Rep,2022
4. Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA vaccine in preventing infection among children aged 5 to 11 years and adolescents aged 12-15 years—PROTECT cohort, July 2021-February 2022.;Fowlkes;MMWR Morb Mortal Wkly Rep,2022
5. Determinants of COVID-19 vaccine uptake in adolescents 12-17 years old: examining pediatric vaccine hesitancy among racially diverse parents in the United States.;Gray;Front Public Health,2022
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Booster vaccination using bivalent DS-5670a/b is safe and immunogenic against SARS-CoV-2 variants in children aged 5–11 years: a phase 2/3, randomized, active-controlled study;Frontiers in Immunology;2024-09-02
2. COVID-19 Vaccine Acceptance among Parents of Children Younger than 12 Years in Saudi Arabia;Indian Journal of Public Health;2024-01
3. Mild Hyperglycaemia in Hospitalised Children with Moderate COVID-19 Infection;Medicina;2023-05-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3